HY Capital (华医资本) is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments, and mergers & acquisitions.
SOHO Tianshan Plaza T1-3203
No.1717 Tianshan Road, Changning District
|2018-10-26||Cloudbreak Therapeutics||Series A||$15.84M|
|2018-04-24||Fushoukang||Series A||Fortune Capital (达晨创投), Fosun Pharmaceutical, Qiheng Investment, and Suzhou Qiyingshe|
|2017-07-20||Symbow Medical||Unattributed VC||$17M||Buchang Pharmaceuticals, National Emerging Industry Guidance Fund, and Sangel Capital|
|2017-04-07||UEG Medical||Series A|
|2015-01-29||Wenjuan.com||Series A||$5.5M||Legend Holdings, and Lenovo Group|